Finance

Beta
Lists
Q2 2026 earnings • released • EPS miss -5.08% • Revenue beat +1.17%
See results
1ESSI:BIT
Essity AB (publ) Class B
€24.40
-4.61%
(-1.18) 1D
May 28, 9:00:02 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 1ESSI...
Mkt. cap
198.33B
Avg. vol.
0.00
Volume
0.00
52-wk high
€28.00
52-wk low
€21.52
No. of employees
36K
Mkt. cap
198.33B
Avg. vol.
0.00
Volume
0.00
52-wk high
€28.00
52-wk low
€21.52
No. of employees
36K
News stories
From sources across the web
Profile
Essity AB is a Swedish multinational company specializing in hygiene and health products headquartered in Stockholm, Sweden. Established in 2017 through a spin-off from the forest products company Svenska Cellulosa Aktiebolaget, Essity operates in approximately 150 countries and serves more than one billion people worldwide with its range of products Essity's name is derived from the words "essentials" and "necessity," reflecting its focus on essential hygiene and health products. Essity's range of products includes personal care items, consumer tissue products, professional hygiene solutions, and medical care goods. The company is known for its well-established brands like TENA, Tork, and Libero. Its products are designed for single use and include items like tissue paper, baby diapers, feminine care, incontinence products, compression therapy, orthopedics and wound care. Essity has approximately 36,000 employees and net sales in 2023 amounted to EUR 13 billion. Wikipedia
About Essity AB (publ) Class B
CEOUlrika Kolsrud
Employees36K
FoundedJun 15, 2017
HeadquartersStockholm, Södermanland, Sweden
SectorHousehold goods
Websiteessity.com
Last report
Jul 16, 2026
Fiscal period
Q2 2026
EPS / Est. (SEK)
SEK 4.59 / SEK 4.83
-5.08%miss
Revenue / Est. (SEK)
35.06B / 34.66B
+1.17%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
34.64B
34.70B
33.18B
35.06B
Cost of goods sold
23.06B
23.00B
22.09B
23.62B
Cost of revenue
23.06B
23.00B
22.09B
23.62B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.52B
6.58B
6.48B
6.76B
Operating expense
6.76B
6.81B
6.73B
7.02B
Total operating expenses
29.82B
29.81B
28.82B
30.64B
Operating income
4.81B
4.88B
4.36B
4.43B
Other non operating income
-
-42.00M
-
-
EBT including unusual items
4.54B
4.45B
3.94B
3.58B
EBT excluding unusual items
4.44B
4.58B
4.10B
4.16B
Income tax expense
1.18B
1.23B
1.04B
883.00M
Effective tax rate
25.97%
27.55%
26.41%
24.69%
Other operating expenses
-
-
-
-
Net income
3.34B
3.21B
2.89B
2.68B
Net profit margin
9.65%
9.25%
8.70%
7.65%
Earnings per share
4.81
4.84
4.44
4.59
Interest and investment income
-
257.00M
-
-
Interest expense
-369.00M
-507.00M
-250.00M
-307.00M
Net interest expenses
-369.00M
-250.00M
-250.00M
-307.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
6.30B
6.38B
5.82B
5.98B
Gain or loss from assets sale
-55.00M
35.00M
-3.00M
13.00M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer